Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wilhelm Schoner. (1992) Endogenous Digitalis-Like Factors. Clinical and Experimental Hypertension. Part A: Theory and Practice 14:5, pages 767-814.
Read now
Read now
Kurt R.H. Repke, JÜRgen Weiland & Karl-Heinz Menke. (1991) Chemical Models for the Chemical Nature of Endogenous Digitalis. Journal of Enzyme Inhibition 5:1, pages 25-32.
Read now
Read now
Theodor H. Weber, Kirsti I. Käpyaho & Pirjo Tanner. (1990) Endogenous interference in imunoassays in clinical chemistry. A rewiev. Scandinavian Journal of Clinical and Laboratory Investigation 50:sup201, pages 77-82.
Read now
Read now
Articles from other publishers (14)
Andrew L. Koons, Lexis T. Laubach, Kenneth D. Katz & Gillian A. Beauchamp. (2020) Mobitz Type II Atrioventricular Heart Block After Candlenut Ingestion. Journal of Osteopathic Medicine 120:12, pages 839-843.
Crossref
Crossref
Philipp von Bismarck, Tobias Ankermann, Paul Eggert, Alexander Claviez, Michael J. Fritsch & Martin F. Krause. (2006) Diagnosis and management of cerebral salt wasting (CSW) in children: the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Child's Nervous System 22:10, pages 1275-1281.
Crossref
Crossref
Sarah A. Spinler, Abdulrazaq S. Al-Jazairi, Judy W.M. Cheng, Shiv Kapoor, Sidney Kobrin & Leslie Shaw. (2000) Predictive Performance Study of Two Digoxin Assays in Subjects With Various Degrees of Renal Function. Therapeutic Drug Monitoring 22:6, pages 729-736.
Crossref
Crossref
Cesar Liendo, Jalal K. Ghali & Steven W. Graves. (1996) A new interference in some digoxin assays: Anti-murine heterophilic antibodies*. Clinical Pharmacology & Therapeutics 60:5, pages 593-598.
Crossref
Crossref
. (1995) Technical Reports. cclm 33:3, pages 157-176.
Crossref
Crossref
Paula A. Schueler, David L. Enfield, Tom M. Fleck, John T. Kingsley & Walter C. Mahoney. 1993. Diagnostics in the Year 2000. Diagnostics in the Year 2000
177
196
.
Mont R. Juchau, Robert J. Walker, J. Paul Fawcett, R. Sutherland, Noel W. Preston, Sanjay Batra, Manju Seth, A. P. Bhaduri, Wilhelm Schoner, James W. Fisher, Hiroshi Ohtaka & Toshio FujitaWilhelm Schoner. 1993. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
249
291
.
Amado J. Pesce & J.Gabriel Michael. (1992) Artifacts and limitations of enzyme immunoassay. Journal of Immunological Methods 150:1-2, pages 111-119.
Crossref
Crossref
Walter C. Mahoney, Kent E. Opheim, Tom M. Fleck, Paula A. Schueler, David L. Enfield & John T. Kingsley. 1992. Immunoassay Automation. Immunoassay Automation
167
190
.
Leondios Yiannakou, Eleni Loucari-Yiannakou & Athanasios Souvatzoglou. (1991) Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids. Clinical Biochemistry 24:6, pages 475-482.
Crossref
Crossref
Bruce J. Schrader, Michael S. Maddux, Susan A. Veremis, Martin F. Mozes, Andrew Maturen & Jerry L. Bauman. (2013) Digoxin‐Like Immunoreactive Substance in Renal Transplant Patients. The Journal of Clinical Pharmacology 31:12, pages 1126-1131.
Crossref
Crossref
D. M. HowarthD. C. SampsonF. H. HawkerA. Young. (2019) Digoxin-like Immunoreactive Substances in the Plasma of Intensive Care Unit Patients: Relationship to Organ Dysfunction. Anaesthesia and Intensive Care 18:1, pages 45-52.
Crossref
Crossref
William J. Wechter & Elaine J. Benaksas. 1990. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
231
260
.
C.P. Weiner, S. Landas & T.J. Persoon. (1987) Digoxin-like immunoreactive substance in fetuses with and without cardiac pathology. American Journal of Obstetrics and Gynecology 157:2, pages 368-371.
Crossref
Crossref